Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19)
Condition(s):COVID-19Last Updated:February 26, 2024Withdrawn
Hide Studies Not Open or Pending
Condition(s):COVID-19Last Updated:February 26, 2024Withdrawn
Condition(s):Extracorporeal Membrane Oxygenation ComplicationLast Updated:November 29, 2023Not yet recruiting
Condition(s):CancerLast Updated:September 21, 2023Completed
Condition(s):Sepsis; Gram-Negative Bacterial Infections; HeparinLast Updated:March 21, 2023Recruiting
Condition(s):Covid19; PneumoniaLast Updated:August 31, 2020Unknown status
Condition(s):Cardiac Surgery; Central Venous Catheter Thrombosis; HeparinLast Updated:September 2, 2022Completed
Condition(s):Recurrent Pregnancy LossLast Updated:February 14, 2022Unknown status
Condition(s):Stable Angina; Angina, Unstable; Non-ST Elevation (NSTEMI) Myocardial InfarctionLast Updated:September 27, 2012Unknown status
Condition(s):Arteriovenous FistulaLast Updated:July 9, 2015Completed
Condition(s):STEMI; Primary PCILast Updated:January 23, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.